CTKB FY 2023 Earnings — Cytek Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CTKBCytek Biosciences, Inc.

$553M

FY 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$193M+17.7% YoY

Gross Profit

$109M56.7% margin

Operating Income

-$28M-14.4% margin

Net Income

-$12M-6.3% margin

EPS (Diluted)

$-0.09

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

$454,000

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$494M

Total Liabilities

$101M

Stockholders' Equity

$393M

Cash & Equivalents

$167M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$193M	$164M	+17.7%
Gross Profit	$109M	$101M	+8.4%
Operating Income	-$28M	-$2M	-1443.5%
Net Income	-$12M	$3M	-571.6%